|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/70 | |
| G01N 33/53 | |||
| G01N 33/567 | |||
| G01N 33/00 | |||
| C07H 21/04 |
| (11) | Number of the document | 3274478 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15888046.8 |
| Date of filing the European patent application | 2015-06-22 | |
| (97) | Date of publication of the European application | 2018-01-31 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/036941 |
| Date | 2015-06-22 |
| (87) | Number | WO 2016/160046 |
| Date | 2016-10-06 |
| (30) | Number | Date | Country code |
| 201562139183 P | 2015-03-27 | US |
| (72) |
CHIEN, David, Y., US
COIT, Doris, Guenzi, US
FUJIHARA, Toshiya, JP
GYENES, Alexander, US
HALL, John, Andrew, US
MEDINA-SELBY, Angelica, US
ZHENG, Jian, US
|
| (73) |
Ortho-Clinical Diagnostics, Inc.,
1001 U.S. Route 202, Raritan, NJ 08869,
US
Grifols Worldwide Operations Limited, Grange Castle Business Park Grange Castle Clondalkin, Dublin 22, IE Ortho Clinical Diagnostics, K.K., 1-11-2 Osaki Shinagawa-ku, Tokyo 141-0032, JP |
| (54) | HCV NS4A/MODIFIED NS3 POLYPEPTIDES AND USES THEREOF |
| HCV NS4A/MODIFIED NS3 POLYPEPTIDES AND USES THEREOF |